ICCS 2020 presented on June 8, 2020. The agenda may be found here.
The ICCS 2020 event highlighted 20 emerging oncology companies who presented their technologies and partnering opportunities in this newly adapted forum. Participants accessed video pitches tailored for this event and had the opportunity to connect with emerging oncology companies from North American and European Innovation Hubs. Slide decks from the video pitches are available HERE.
Cutting-edge oncology innovations were presented as brief pitch presentations.
ICCS 2020 provided registrants with an opportunity to learn about the latest innovations presented in collaboration with leading North American and European industry clusters.
More information about the 2020 AGENDA and PRESENTING COMPANIES may be found here.
The ICCS 2020 EVENT GUIDE may be downloaded here.
ICCS 2020 - Digital Event Agenda
Session Titles and List of Company Pitches from Promising Oncology Innovators
ICCS 2020's Virtual Event showcased emerging oncology companies advancing novel therapeutic, diagnostic, and digital solutions for cancer patients. The event featured four thematic sessions highlighting 20 companies from Massachusetts, Philadelphia, Quebec, the UK Golden Triangle, the Nordics, France, and Switzerland.
|
Session 1: Targeting Novel Mechanisms
Welcome from the ICCS 2020 Organizing Partners. Session 3: I-O, Oncolytic Viruses and Vaccines
"Future Tech Industries" by DNB |
Session 2: I-O and Cell Therapy
Takeda Presentation, Alexandra Huhalov, Search & Evaluation Lead, Oncology, Center for External Innovation, Takeda Pharmaceuticals. Session 4: Diagnostics and Digital Health Interventions
"Monitoring in the COVID Environment" by Francisco Vega, VP Global Clinical Monitoring, Precision for Medicine. |
ICCS 2020 was sponsored by:
|
|
|
|
Organizers:
